Wuhan Hhd Supply Trelagliptin Succinate CAS 1029877-94-8 Triglitastat Succinate

• Customization: Available
• Powder: Yes
• Customized: Non-Customized
• Model NO.: HHD Pharm
• Certification: Enterprise Standards
• Suitable for: Adult
• State: Powder
• Purity: >98%
• Color: White
• Grade: Pharmaceutical Grade
• Test Method: HPLC, Lcms, Hnmr
• COA: Available
• Transport Package: Alumininum Foli Bags
• Specification: 10g, 50g, 200g, 1kg, 5kg
• Trademark: hhdpharm
• Origin: China

Product Description

Wuhan HHD Supply Trelagliptin Succinate CAS 1029877-94-8 Triglitastat Succinate

 

Product Name: Trelagliptin succinate
Synonyms: Trelagliptin Succinate (SYR-472);SYR 111472 succinate;SYR-472 succinate;Trelagliptin succinat;SYR-472 Trelagliptin succinat;Trelagliptin succinate(SRY-472);Trelagliptin succinate SYR 111472 succinate;Triglitastat succinate
CAS: 1029877-94-8
MF: C22H26FN5O6
MW: 475.48
EINECS: 627-030-2

Melting point: 168-170°C
Boiling point: 843.3±75.0 °C
Density: 1.37±0.1 g/cm3
Storage temp.: -20°C Freezer
Appearance: White Powder

Description:

Similar to omarigliptin, trelagliptin succinate (XIX) is a highly selective, orally delivered inhibitor of DPP-4 developed by Takeda Pharmaceuticals and approved in Japan in March 2015 for the treatment of type 2 DM. Interestingly, trelagliptin is structurally similar to alogliptin, a DPP-4 inhibitor also marketed by Takeda and described in our 2010 review, differing only in the presence of a in the 5-position of the cyanobenzyl moiety. Both trelagliptin and alogliptin are potent inhibitors of DPP-4, with IC50s of 1.3 and 5.3 nM, respectively. Notably, while similar drugs are dosed once daily, trelagliptin is the first DPP-4 inhibitor approved for onceweekly dosing. Kinetic analysis has revealed that trelagliptin is a substrate-competitive, reversible, slow-binding inhibitor (t1/2 for dissociation = ca. 30 min) of DPP-4, although the dissociation time is insufficient to explain its long-acting effects. In a phase III trial, once-weekly trelagliptin (100 mg) showed similar efficacy and safety to once-daily alogliptin (25 mg) in patients with type 2 DM inadequately controlled by diet and exercise. The medicinal chemistry discovery of trelagliptin and alogliptin as well as reviews of this class of compounds have been published.

 

Packaging & Shipping

Our service

1.COA/MSDS/ROS/MOA Available.
2.Any inquiries will be replied within 12 hours.
3. Dedication to quality, supply & service.
4.Strictly on selecting raw materials.
5.Reasonable & competitive price, fast lead time.
6.Faster delivery:Sample order in stock and one week  for bulk production.
7.We have strong cooperation with DHL, TNT, UPS, FEDEX, EMS. Or you also can choose your own shipping forwarder.
8.Timely after-service resolves your worry for internation trade.
9.Payment: